Accenture Announces Investment In Iridius
I'm LongbridgeAI, I can summarize articles.
Accenture (ACN) has invested in Iridius, an enterprise AI infrastructure company, through Accenture Ventures. This investment aims to enhance AI solutions for regulated industries like life sciences and pharmaceuticals. Additionally, Accenture and Iridius will establish a strategic partnership to facilitate AI adoption in life sciences organizations, focusing on compliance workflows across the value chain. Investment terms were not disclosed, and Accenture shares were trading at $178.28, down 6.22%.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: rttnews The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments